Physician profile
Terri Strobel
NPI 1932328143
$2,185.80
in general payments reported to CMS, 2019-2025
22 companies · $650 in 2025
The $650 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $246 · 2023: $261 · 2024: $739 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.42 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $532.71 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $198.92 | 2024-2025 | |
| Lilly USA, LLC | $183.45 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $182.63 | 2021-2025 | |
| Astellas Pharma US INC | $179.51 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $170.73 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $126.19 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $107.24 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Amgen INC. | $95.20 | 2023-2025 | Otezla, Repatha, Krystexxa |
| Inspire Medical Systems, INC. | $85.76 | 2024-2025 | Inspire |
| Daiichi Sankyo INC. | $71.86 | 2021-2023 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $46.41 | 2023-2025 | Farxiga |
| Nevro Corp. | $33.02 | 2024 | Senza |
| Optinose US, INC. | $24.74 | 2024 | |
| Janssen Pharmaceuticals, INC | $23.24 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.45 | 2025 | Rexulti |
| Boston Scientific Corporation | $18.73 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.63 | 2022 | |
| Genentech USA, INC. | $18.21 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.02 | 2022 | |
| Ibsa Pharma INC. | $16.65 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Strobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.